Savior Lifetec Corporation (4167) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Savior Lifetec Corporation (4167:TWSE), powered by AI.

Current Price
$19.95
Sector
Healthcare
What is the Savior Lifetec Corporation stock price forecast?

Savior Lifetec Corporation is currently trading at $19.95. View real-time AI analysis on Alpha Lenz.

What is Savior Lifetec Corporation insider trading activity?

View the latest insider trading data for Savior Lifetec Corporation on Alpha Lenz.

What is Savior Lifetec Corporation's P/E ratio?

View Savior Lifetec Corporation's valuation metrics on Alpha Lenz.

Savior Lifetec Corporation

TWSE · 4167
NT$19.95+0.10(+0.50%)
Ask about Savior Lifetec Corporation's future dividend policy...
Alpha Chat Insight

Savior Lifetec Corporation's ROE is 14.7%. Explore profitability and growth together.

Ask for details

Company Overview

Savior Lifetec Corporation is a biotechnology and healthcare company specializing in the development, production, and supply of sterile active pharmaceutical ingredients (APIs) and finished dosage formulations, notably for injectable medicines. Focused on specialty injectables, the company’s product portfolio includes a range of carbapenem antibiotics, such as imipenem, meropenem, and ertapenem, as well as other pharmaceutical compounds like paliperidone palmitate and prucalopride succinate. With vertically integrated, state-of-the-art manufacturing facilities and GLP-compliant R&D centers, Savior Lifetec Corporation emphasizes quality, innovation, and regulatory compliance, serving both domestic and international pharmaceutical markets. Founded in 1993 and based in Miaoli County, Taiwan, Savior Lifetec plays a vital role in advancing the pharmaceutical industry by providing essential injectable drugs that support hospital and clinical needs, contributing to global health and medication accessibility.

SectorHealthcare
IndustryBiotechnology
0

Company Statistics

FY 2025

Profile

N/AMarket Cap
NT$1.20BRevenue
0.00Shares Out
0Employees

Margins

35.23%Gross
53.89%EBITDA
16.50%Operating
44.44%Pre-Tax
44.41%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

-1.72%Rev 3Yr
-8.04%Rev 5Yr
N/AOp Inc 3Yr
-3.95%Op Inc 5Yr
144.95%Net Inc 3Yr
16.29%Net Inc 5Yr

Returns

12.47%ROA
14.75%ROE
12.60%ROIC

Financial Health

NT$823.40MCash & Cash Equivalents
NT$-420.10MNet Debt
10.67%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Savior Lifetec Corporation (ticker: 4167) is a company listed on TWSE in the Healthcare sector (Biotechnology).

The current price is 19.95 with a P/E ratio of -x and P/B of -x.

ROE is 14.75% and operating margin is 16.50%. Annual revenue is $1.2B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Savior Lifetec Corporation (4167) Stock Forecast 2026 $19.95 — Price, Financials & Analyst Targets | Alpha Lenz